Purpose: This study analyzed the influence of substance P (SP) on growth factors related to wound healing in mice in the presence of infectious keratitis.
O ne of the most common isolates from patients with microbial keratitis is Pseudomonas aeruginosa. 1 It is classified as an opportunistic Gram-negative bacterium that causes keratitis in patients who are immunocompromised and in extended wear contact lens users. 2 The infection is rapid and triggers a host immune response that can lead to vision loss. 3 Previous experimental studies using BALB/c (T-helper cell type 2 responder, resistant) and C57BL/6 (T-helper cell type 1 responder, susceptible) mice have characterized their responses to P. aeruginosa infection and shown that C57BL/6 mice undergo more severe disease with corneal perforation when compared with BALB/c mice. 4 These studies have examined the role of the host inflammatory response, including the production of cytokines and chemokines and the participation of various cells (eg, macrophages, 5 neutrophils, 6 T lymphocytes, 7 and natural killer cells 8 ) in animal models of the disease. In macrophages, gene expression profiling has shown that Gram-negative bacteria induce transcriptional activation of a common host response that induces genes in these cells expressing a type 1 macrophage (M1) program. 9 M1 polarized cells, prototypical in T-helper cell type 1 responder strains of mice, such as C57BL/6, 10 are characterized by production of interleukin (IL)-12, tumor necrosis factor alpha (TNF-a), macrophage inflammatory protein-2 (MIP-2), and high levels of nitric oxide synthase 2 (NOS2). 11, 12 Excessive or prolonged M1 polarization can lead to tissue injury and contribute to pathogenesis, as shown in a previous work from this laboratory. 13 In contrast, Thelper cell type 2 responder mice (BALB/c) possess a higher population of alternatively activated macrophages, designated M2 cells, that produce antiinflammatory mediators, such as IL-10, IL-1 receptor antagonist (ra), and type II IL-1 decoy receptor, 12 that upregulate production of arginase 1 10 and are critical to innate immunity and disease resolution. 13 An important role of the innate immune system (and general wound healing) in the cornea is the maintenance of homeostasis. Furthermore, in recent years, the link between the immune system and neuropeptides has been well established in numerous systems, 14, 15 including models of corneal infection. 16, 17 Evidence for this link includes the presence of neuropeptide receptors on and the proximity of neuronal terminals to leukocytic cells (ie, macrophages), as well as the ability of these cells to synthesize peptides. 15 One such peptide is SP that interacts with the innate immune system to stimulate the release of cytokines and augment inflammation in various experimental models. [18] [19] [20] [21] SP is an 11-amino acid member of the tachykinin family of neuropeptides that stimulates the production of proinflammatory cytokines (eg, IL-1b, TNF-a, and interferon gamma) through activation of transcription factor nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB), creating exacerbated states of the disease. 22 In contrast, in noninfectious wound or trauma models, it is thought to be essential in tissue repair and has healing properties when administered exogenously. [23] [24] [25] Moreover, SP-mediated cytokine release and the chemoattraction of infiltrating leukocytes (neutrophils, macrophages) aids in healing, but can cause damage if left unregulated, 22, 23 in part, because of the antiapoptotic effects of SP. 26 It has been shown that levels of SP are low in BALB/c mice and, when the neuropeptide is administered exogenously via intraperitoneal injection, corneal disease is worsened with increased cellular infiltrate, bacterial number, proinflammatory cytokines/chemokines, NF-kB activation, and reduced levels of antiinflammatory cytokines, all of which result in corneal perforation. 16, 27 FIGURE 1. ELISA analysis of SP (A) and IL-1b (B) protein levels. Samples are taken from normal cornea and at 3 days postinfection and duodena, harvested 3 days postinfection from corneally infected mice. Samples compare mice injected with SP versus PBS (n = 5/group/treatment/ assay = 20 mice). Important components in corneal wound healing after noninfectious trauma are growth factors, naturally occurring peptides that facilitate cell-to-cell communication and enhance cell proliferation and migration and tissue function. Of interest are 3 classic growth factors: epidermal growth factor (EGF), hepatocyte growth factor (HGF), and fibroblast growth factor-7/keratinocyte growth factor (FGF-7/KGF). Their presence and function in noninfectious wound healing in the cornea has been firmly established [28] [29] [30] ; however, little information is available regarding these growth factors in a model of corneal infection. 31 Thus, the purpose of the current study was to test the regulatory role of SP on growth factor production in BALB/c mice, whose cornea normally does not perforate after infection. 4 We provide insight into the dual role of SP in this model of bacterial infection. We show that SP has a dual role in this model of bacterial infection, unexpectedly upregulating growth factor production. This was accompanied by macrophage-specific upregulation of proinflammatory cytokines, downregulation of antiinflammatory cytokines, upregulation of antiapoptotic genes, and a decrease in arginase-producing macrophages (M2 cells), important in stromal healing in these mice. 10 All these lead to worsened disease, despite the stimulatory effects on growth factor production, and contraindicate clinical use of SP in the cornea to promote wound healing, if an infection is present or suspected. 
Bacterial Culture and Infection
Pseudomonas aeruginosa cultures (strain 19660; purchased from the American Type Culture Collection, Manassas, VA) were grown in peptone tryptic soy broth as described by Hazlett et al. 32 The central cornea of each anesthetized mouse was scarred with a sterile needle and a 5-mL inoculum (1·10 6 colony forming units per microliter) applied. 
SP Treatment
BALB/c mice were anesthetized and injected intraperitoneally with 100 mL of sterile phosphate-buffered saline (PBS) containing 15-mM SP (Sigma-Aldrich, St Louis, MO) each day from the day before infection (d = −1) to 5 days after infection [for messenger RNA (mRNA)] or 7 days (for protein). Controls were similarly injected with sterile PBS and the disease was graded after infection on days 1, 3, 5, and 7, using a clinical score system described by Hazlett et al. 32 
Real-Time Reverse Transcriptase-Polymerase Chain Reaction
Mice were killed and normal and infected corneas from SP-treated or PBS-treated mice (n = 5/treatment/time = 30 mice) were removed (1, 3, and 5 days). Each cornea was briefly stored in RNA STAT-60 (Tel-Test, Friendsville, TX) at −20°C before processing. 16 To assess transcriptional changes, mRNA levels of EGF, HGF, FGF-7, caspase-3, and B-cell lymphoma-2 (Bcl-2) were tested by real-time reverse transcriptase-polymerase chain reaction (RT-PCR; MyiQ Single Color Real-Time PCR Detection System; Bio-Rad, Hercules, CA). Real-Time SYBR Green/Fluorescein PCR Master Mix (Bio-Rad) was used for the PCR reaction with primer concentrations of 5 mM, as described previously by McClellan et al. 16 Fold differences in gene expression were calculated after normalization with b-actin. Growth factor primer pair sequences used for real-time RT-PCR were purchased from SABiosciences (Frederick, MD). Other primers for caspase-3, Bcl-2, and b-actin have been described previously by Zhou et al. 26 
Enzyme-Linked Immunosorbent Assay
After SP or PBS treatment, translational effects (protein levels) for SP, IL-1b, and the growth factors were determined using enzyme-linked immunosorbent assay (ELISA) kits (R&D Systems, Minneapolis, MN) as described previously by McClellan et al. 16 SP and IL-1b protein levels were determined from individual (SP-or PBS-treated) normal and infected BALB/c corneas (n = 5/group/treatment/assay = 20 mice) and uninfected duodenum (taken from 10 corneally infected mice) at 3 days after infection. The assay sensitivity for SP was 16.8 to 43.8 pg/mL and ,3.0 pg/mL for IL-1b.
For the growth factors, mice were killed and individual (SP or PBS treated) normal and infected (1, 5, and 7 days) corneas (n = 5/treatment/time = 30 mice) were harvested. Corneas were individually homogenized in sterile PBS containing 0.1% Tween 20 and a protease inhibitor cocktail (Roche Diagnostics, Indianapolis, IN) as described previously by McClellan et al. 16 The reported sensitivity of the EGF assay was 0.32 to 1.64 pg/mL. Sensitivity for the HGF and FGF-7 assays was determined by comparison with a standard curve concentration (R&D Systems). A human FGF-7 ELISA assay kit was used because a commercial murine kit was not available; others have established its effectiveness for murine samples. 33 Immunostaining Normal and P. aeruginosa-infected (5 days) eyes were enucleated from SP-treated or PBS-treated BALB/c mice (n = 5/treatment/growth factor = 30 mice), embedded in optimal cutting temperature compound, and snap frozen in liquid nitrogen. Sections (10 mm) were cut, fixed in acetone, and incubated in blocking agent as described previously by McClellan et al. 16 Sections were incubated with individual primary antibodies (goat anti-mouse EGF/HGF/FGF-7; 1:10; R&D Systems) in blocking agent for 1 hour, rinsed with buffer, and incubated for another hour with Alexa Fluor 546 donkey anti-goat immunoglobulin G (IgG) secondary antibody [(1:1500; Molecular Probes, Eugene, OR) in 0.01 M Tris-HCl]. In another experiment (n = 5/treatment/group = 60 mice), sections were incubated with antibodies specific for growth factors and macrophage-specific primary antibody rat anti-mouse F4/80 (1:100; Santa Cruz Biotechnologies, Inc, Santa Cruz, CA) or fibroblast-specific rat anti-mouse ER-TR7 (1:50; Santa Cruz Biotechnologies, Inc). Then, appropriate secondary antibodies were applied: Alexa Fluor 546 goat anti-rat IgG (1:1500; Molecular Probes) and cyanine dye 5 conjugated donkey anti-rat IgG (Jackson Immunoresearch, West Grove, PA).
In the next experiment (n = 5/treatment/group = 20 mice), sections were incubated with macrophage-specific primary antibody (F4/80) followed by rabbit anti-mouse NOS2 (M1 phenotype) or arginase (M2 phenotype; 1:200; Santa Cruz Biotechnologies, Inc). Then, secondary antibodies (in 0.01 M Tris-HCl) were applied: Alexa Fluor 546 goat anti-rat IgG (1:1500; Molecular Probes) and Alexa Fluor 633 goat anti-rabbit IgG (Molecular Probes).
All sections were incubated with a nuclear acid stain (SYTOX Green, 1:20,000; Lonza, Walkersville, MD) and controls for each of the experiments were treated the same, with the exception that each primary antibody was replaced by the same host species IgG. Digital images were captured on a confocal laser scanning microscope (TCS SP2; Leica Microsystems, Exton, PA).
Semiquantitative Cell Counts
Three representative confocal micrographs (magnification ·208) per group were analyzed essentially as described by Sensoo and Joyce. 34 Briefly, the total number of either F4/ 80-positive or ER-TR7-positive cells were counted in four 150 mm 2 areas of each micrograph (12 areas per group). Dual labeled cells (positive for each growth factor and either specific label above) were enumerated, averaged, and expressed as a percentage of the total number of F4/80-positive or ER-TR7-positive cells. In a separate experiment, stromal F4/80-labeled macrophages positive for NOS2 (M1 cells) or arginase (M2 cells) were counted similarly.
Macrophage Culture and Real-Time RT-PCR
BALB/c mice (n = 10 mice) were injected intraperitoneally with 1 mL of a 3% Brewer thioglycollate medium (Becton-Dickinson, Sparks, MD) to stimulate macrophages into the peritoneal cavity and to increase yield. 35 Seven days later, macrophages were harvested from the collected peritoneal fluid, and centrifuged at 1000 rpm for 10 minutes. The remaining pellet was resuspended with 10 mL of Dulbecco modified Eagle medium (Invitrogen, Carlsbad, CA) and a 10 mL aliquot was stained with trypan blue dye (1:1; Invitrogen) for cell counts with a hemacytometer. Cells were seeded in 12-well plates at a density of 3 · 10 6 cells per well (n = 3 wells per group) and incubated at 37°C for 1 hour. Media were removed and adherent cells were stimulated as follows: 10 mL of 1 mg/mL lipopolysaccharide (LPS; L9143 from P. aeruginosa, serotype 10; Sigma-Aldrich) ± 1 mL of 1 · 10 −9 M or 1 · 10 −12 M SP 36 (Sigma-Aldrich), SP alone, or media (control) to a total volume of 1 mL and incubated for 18 hours at 37°C. Then, cells and media were removed from the wells and centrifuged for 5 minutes at 7300 rpm. Pellets were reconstituted in RNA STAT-60 (Tel-Test) and processed for mRNA as described above. IL-1b, IL-18, MIP-2, TNF-a, NF-kB, and transforming growth factor beta (TGF-b) mRNA levels were tested as described above using previously published primer sequences. 16 
Statistical Analysis
An unpaired 2-tailed Student t test was used to determine the statistical significance of the real-time RT-PCR, ELISA, and cell counts. Data were considered significant at P , 0.05. All experiments were repeated at least once to ensure reproducibility and data from a representative experiment are shown as mean ± SEM.
RESULTS

ELISA Analysis of SP and IL-1b
To determine if SP injection elicited systemic effects, individual normal and infected corneas and normal duodena were harvested 3 days after infection, and protein levels for SP and IL-1b were assayed (Figs. 1A, B ). No significant difference in SP levels was detected in either the normal cornea or duodenum after SP versus PBS treatment. However, in the infected cornea, SP versus PBS treatment increased local SP levels (P = 0.03; Fig. 1A ). IL-1b protein (Fig. 1B) was undetectable in the normal cornea in either SP-treated or PBStreated mice. However, after 3 days of infection, significantly (P = 0.04) increased levels of the cytokine were seen in SP-treated over PBS-treated samples. No differences were detected between groups in the duodenum (Fig. 1B) . Figure 2 shows corneal mRNA (A-C) and protein (D-F) levels of the growth factors after SP versus PBS treatment. At 1 day after infection, EGF mRNA levels were increased (P , 0.0001) in the cornea of SP-treated versus PBS-treated mice ( Fig. 2A) ; however, there was no difference between groups in the normal uninfected cornea or at 5 days after infection. EGF protein levels (Fig. 2D ) were significantly decreased in the SP-treated versus PBS-treated group at 1 day after infection (P = 0.0001), but no difference between groups was detected in the normal cornea or after 5 or 7 days of infection. SP treatment resulted in a significant increase in HGF mRNA expression ( Fig. 2B ) in the normal cornea (P = 0.006) and at 5 days after infection (P = 0.02) when compared with PBS controls. No difference was detected at 1 day after infection between these groups. HGF protein ( Fig. 2E ) was significantly increased in normal cornea and at 1, 5, and 7 days of infection after SP treatment (P , 0.0001, 0.003, ,0.0001, and ,0.0001, respectively). FGF-7 mRNA expression ( Fig. 2C ) was significantly increased at 5 days after infection (P = 0.03) after SP treatment, with no difference between groups in the normal cornea or at 1 day of infection. FGF-7 protein levels (Fig. 2F ) were significantly increased after SP treatment after infection (1, 5, and 7 days; P , 0.0001 for each) with no difference between groups in the normal cornea.
Real-Time RT-PCR and ELISA Analysis of the Growth Factors
Immunofluorescent Staining
Qualitative differences in immunostaining for the growth factors (red) were detected between SP-treated versus PBS-treated groups (Fig. 3) after infection (5 days). Similar EGF staining was observed primarily in the epithelium in both treatment groups (Figs. 3A, B) . HGF staining was observed in the epithelium and stroma but was more intense in the SP-treated (Fig. 3D ) versus PBS-treated ( Fig. 3C ) group. More intense staining also was seen for FGF-7 after SP ( Fig. 3F ) versus PBS (Fig. 3E ) treatment. Representative same host species IgG controls are shown for the PBS-treated ( Fig. 3G ) and SP-treated ( Fig. 3H ) groups.
Dual immunostaining was used to investigate the cellular origin of the growth factors. Cells were stained for an individual growth factor and either fibroblast (ER-TR7) or macrophage (F4/80) markers 5 days after infection. The results are shown in Figures 4 and 5 , respectively. There was no qualitative difference in the number of dual-labeled cells that stained positively for EGF and ER-TR7 (red, blue, respectively; Figs. 4A, B ) or EGF and F4/80 (red, blue, respectively; Figs. 5A, B) in the PBS-treated versus SP-treated groups (merged images shown). However, SP-treated mice had qualitatively more fibroblasts and macrophages that stained positively for HGF ( Figs. 4D, 5D) 
Semiquantitative Cell Counts
To confirm the qualitative dual-immunostaining data, semiquantitative cell counts were done 5 days after infection (Fig. 6 ). The percentages of dual-labeled EGF-positive fibroblasts and/or macrophages (expressed as a percentage of total fibroblast or macrophage labeling) were not significantly different between the SP-treated versus PBS-treated groups (Fig. 6A ). However, a significant increase in dual-labeled HGF-positive fibroblasts (P , 0.0001) and macrophages (P , 0.0001) and dual-labeled FGF-7-positive fibroblasts (P , 0.0001) and macrophages (P , 0.0001; expressed as a percentage of total fibroblast or macrophage labeling) was seen in the SP-treated versus PBS-treated controls (Figs. 6B, C) .
Macrophage Phenotype and Cell Counts
Dual immunostaining also was used to test whether SP treatment affected macrophage polarization in the stroma of the infected cornea at 5 days after infection and the data are shown in Figure 7 . NOS2-positive (blue) M1 macrophages (red) were detected (merged image shown) in corneas of mice treated with PBS ( Fig. 7A) or SP (Fig. 7B) and seemed similar. Arginase-positive (blue) M2 macrophages (red) were also detected (merged image shown) in the infected stroma of PBS-treated ( Fig. 7C ) and SP-treated ( Fig. 7D ) mice but seemed qualitatively decreased in the SP group. Representative same host species IgG controls are shown for the PBStreated ( Fig. 7E ) and SP-treated (Fig. 7F) groups. At 5 days after infection, macrophages that were either arginase or NOS2 positive were quantitated and expressed as a percentage of total F4/80-positive macrophages, essentially as described above. The data are shown in Figure 8 . There was no significant difference between treatment groups in the percentage of M1 macrophages; however, a significant (P = 0.003) decrease in the percentage of M2-labeled cells was seen after SP versus PBS treatment.
Real-Time RT-PCR of Macrophage Cytokines
Because SP decreases the number of M2-positive cells with no difference in the M1 cell population, we next tested its effects in vitro on macrophage production of proinflammatory (eg, MIP-2, TNF-a, NFkB, IL-1b, IL-18; Figs. 9A-D, F) and antiinflammatory (TGF-b; Fig. 9E ) molecules to determine if, in addition to modulating growth factors, SP enhances the proinflammatory cytokine pathway in these cells. The data show that the effects of SP necessitated the presence of LPS, and SP alone did not give similar effects. Specifically, after 18 hours of stimulation, SP (10 −9 M and 10 −12 M) and LPS significantly increased macrophage mRNA levels of MIP-2 ( Fig. 9A ; P = 0.002 and P = 0.001), TNF-a ( Fig.  9B ; P = 0.03 for both), NF-kB ( Fig. 9C ; P = 0.04 and P = 0.02), and IL-1b ( Fig. 9F ; P = 0.002 and P = 0.02), whereas SP and LPS decreased TGF-b ( Fig. 9E ; P = 0.03 and P = 0.04), compared with stimulation with LPS alone. Both concentrations of SP (in the presence of LPS) elevated IL-18 mRNA levels, but this was significant only at the higher concentration of SP (10 −9 M; Fig. 10F ; P = 0.02). Control wells were incubated with media alone.
Real-Time RT-PCR for Bcl-2 and Caspase-3
Because SP also has been shown to delay apoptosis in vivo, 26 resulting in a persistence of infiltrating neutrophils, apoptotic genes were measured in elicited BALB/c macrophages stimulated with LPS (with or without SP; 10 −9 M and 10 −12 M). Antiapoptotic Bcl-2 ( Fig. 10 ) was significantly increased after stimulation with LPS plus either concentration of SP (P , 0.0001 and P = 0.02) compared with LPS treatment alone. Levels of proapoptotic caspase-3 were below the level of detectability in the macrophage samples (data not shown).
To substantiate the above in vitro data, corneal samples were used to probe for Bcl-2 and caspase-3. In the normal cornea and at 1 and 5 days after infection (Fig. 11A) , there was a significant increase in Bcl-2 mRNA (P = 0.003, 0.03, and 0.03, respectively) with no difference at 3 days of infection after SP versus PBS treatment. Caspase-3 was detectable in the cornea (Fig. 11B) and was decreased in the normal uninfected SP-treated versus PBS-treated groups and after 5 days of infection (P , 0.0001 and P , 0.0001, respectively). No significant change was seen at days 1 or 3 after infection.
DISCUSSION
SP regulates numerous aspects of immune function in that it can either potentiate damage or promote healing. [21] [22] [23] [24] [25] [26] Hong et al 23 characterized SP as an "injury-inducible factor" that acts early in the repair process after wounding, enhancing fibroblast proliferation, with a similar function after burn injury. 37 In contrast, SP has been shown to enhance keratitis in the P. aeruginosa-infected BALB/c mouse cornea, resulting in rapid influx of neutrophils into the site of infection and delaying their apoptosis. 16, 26 Despite these documented effects, that study did not determine whether systemic effects of intraperitoneal injection of SP played a role in these events. 16 Therefore, in the current study, we similarly tested and established that injection of SP did not induce systemic effects and that significantly elevated levels of the neuropeptide were observed only in the infected cornea, and not the duodenum (a peripheral organ site tested). To confirm these results, we also tested levels of IL-1b in both sites and found elevated levels of the cytokine only in the infected cornea, with no differences seen in the duodenum. Together, these data provide evidence that there is no detectable systemic effect after intraperitoneal injection of SP in this model. Thus, FIGURE 9 . In vitro mRNA expression of proinflammatory and antiinflammatory cytokines in macrophages. Samples compare stimulation with LPS with or without SP (at 2 concentrations), SP alone, and media (control; n = 10 mice). current work was able to reasonably test the hypothesis that a contributing factor of enhanced disease in the cornea after SP injection results from a decrease in growth factor production. Growth factors are instrumental in the evolution and resolution of inflammation. They are naturally occurring and facilitate cell-to-cell communication to enhance cell proliferation and migration, essential to restoring tissue functionality after injury. 30, [38] [39] [40] [41] Regarding growth factors and regulation by SP, studies have demonstrated that SP has angiogenic properties, including increasing vascular endothelial growth factor-A production by epidermal granulocytes 42 and inducing growth of vascular endothelial cells into the cornea. 43 Topical administration of SP and insulin-like growth factor-1 to the cornea after noninfectious injury has been shown to synergistically facilitate epithelial migration during wound closure. 44 To date, however, information regarding SP regulation of growth factors, known to be important in noninfectious wound healing (including EGF, HGF, and FGF-7/KGF), is not available in the infected cornea.
For EGF, Lai et al 45 provided evidence that the spatiotemporal expression of elevated EGF paralleled increased SP immunoreactivity in the skin, whereas damage to SP-positive neurons decreased the EGF levels, worsening the disease outcome. In contrast, the current study found that after SP injection, decreased protein levels for EGF occurred early (1 day after infection), despite elevated levels of mRNA at a similar time. No difference in either mRNA or protein levels of EGF was observed between groups later in disease. Because previous studies on EGF have linked elevated levels of the growth factor with proliferation, migration, and differentiation of epithelial cells, 30 it seems difficult to conclude that the early (but not later in disease) decrease in EGF protein levels contributes directly to increased disease severity, despite our prediction.
Another growth factor, HGF, is a potent factor in epithelial cell and keratinocyte proliferation and motility in the cornea 41, 46, 47 and other tissues. 48 In this regard, primary corneal epithelial cells were treated in vitro with exogenous HGF that induced marked cellular proliferation. 49 In another in vitro study, HGF treatment enhanced the migration, growth, and DNA synthesis of human keratinocytes. 50 The current study unexpectedly found that after injection of SP, HGF mRNA and protein levels are elevated up to 7 days after infection. Immunostaining and cell counts supported these data showing increased epithelial and stromal HGF labeling after SP treatment with an increase in the percentage of HGF-positive fibroblasts and macrophages. SP also increased expression of FGF-7/KGF in the infected cornea in a pattern similar to HGF, increasing expression of the growth factor at both the mRNA and protein level. FGF-7 is an epithelial cellspecific mitogen that is secreted by stromal fibroblasts. 51 Stimulation of human keratinocytes with FGF-7 in vitro strongly enhances their proliferation and differentation. 52 Furthermore, topical application of FGF-7 to central corneal epithelial wounds accelerates healing with all wounds healed in the FGF-7-treated group by 72 hours after injury. 53 However, in the SP-treated infected BALB/c cornea, despite elevated levels of the growth factors, repair of corneal tissues does not occur. To explore this further, we examined putative cell types and mechanisms that might contribute to this outcome.
Both fibroblasts and macrophages are sources of growth factors in the cornea, and SP has been shown by others to increase their proliferation. 39, 40, 54, 55 Using dual immunostaining for either fibroblasts or macrophages, together with staining for each of the growth factors, followed by cell counts, the percentage of EGF-positive cells was no different for either cell type between SP versus control groups. In contrast, SP treatment significantly increased the percentage of HGFpositive and FGF-7-positive cells, consistent with elevated levels of these growth factors at both the mRNA and protein level. Moreover, we hypothesized that this increase in cell number may be the result of proliferation 39, 41 or the persistence of these cells in the cornea, perhaps because of decreased apoptosis, 26, 37 as shown before for neutrophils. To test this in vitro, elicited macrophages were stimulated with LPS with or without SP. After LPS and SP treatment, the antiapoptotic gene, Bcl-2, mRNA levels were increased, whereas mRNA levels of the proapoptotic gene, caspase-3, were below the level of detectability. To confirm these in vitro data, we also tested whole cornea for these genes and confirmed that mRNA levels of Bcl-2 were increased and that caspase-3 was detectable and, as anticipated, was decreased. Past studies have demonstrated similar findings regarding apoptotic genes in trauma models of injury (burn). 37 In fact, blocking SP binding to its major receptor, neurokinin-1, improved the disease by increasing the proapoptotic gene, caspase-3, whereas the antiapoptotic gene, Bcl-2, was decreased in the infected cornea of (susceptible) C57BL/6 mice that exhibit high levels of SP in the cornea. 27 Also, blocking SP interaction with its receptor has been shown to induce apoptosis in a human laryngeal carcinoma cell line. 56 Taken together, these data support the antiapoptotic properties of SP that can contribute to stromal tissue damage, which may provide a source of nutrients for bacterial growth, and worsened disease outcome after P. aeruginosa infection. 57 Another contributory effect leading to increased pathogenesis after SP treatment was also explored in vitro in elicited LPS-stimulated macrophages. Neurokinin-1 receptors for SP are present on these cells and during periods of stress, SP binds to this receptor with high affinity, 58 releasing proinflammatory cytokines (ie, IL-1b, IL-6, and TNF-a), as well as increasing cellular phagocytic and chemotactic capacity. 25, 37 Thus, cytokine mRNA levels were measured in vitro after SP treatment (with or without LPS) in BALB/c elicited macrophages. SP with LPS increased the production of proinflammatory cytokines (eg, IL-1b) while decreasing antiinflammatory cytokines (eg, TGF-b). These data led us to hypothesize and test whether SP upregulated M1 (NOS2 positive) and downregulated M2 (arginase positive) types of macrophages, contributing to worsened disease. However, immunostaining and cell counts provided evidence that only M2 type cells were reduced, with no shift in the M1 population between treatment groups.
In summary, herein, we provide insight into the dual role of SP in this model of bacterial infection. Evidence has been provided to show the effects of SP on growth factors and stromal cells (eg, macrophages and fibroblasts) in the infected cornea. The neuropeptide upregulated growth factors (HGF and FGF-7), but this was accompanied by upregulation of proinflammatory cytokines and antiapoptotic genes along with downregulation of antiinflammatory cytokines and proapoptotic genes. Furthermore, the neuropeptide decreased the number of M2 types of macrophages, associated with tissue repair, with no effect on M1-type cells, associated with tissue destruction, all of which contribute to worsened disease, despite elevated levels of the growth factors. Thus, the data contraindicate the use of SP in an infected cornea, despite its clinical efficacy and ability to promote corneal wound healing in the absence of infection. 59 
